Contributors. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .xiii
Foreword . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . xxvii
Foreword to the First Edition. . . . . . . . . . . . . . . . . . . . . . . xxix
Preface. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . xxxi

SECTION 1
Foundation Issues
Section Editor: L. Michael Posey
1. Pharmacoeconomics: Principles, Methods,
and Applications . . . . . . . . . . . . . . . . . . . . . . . . . . 1
Lisa A. Sanchez
2. Health Outcomes and Quality of Life . . . . . . . . . 3
Stephen Joel Coons
3. Evidence-Based Medicine . . . . . . . . . . . . . . . . . . . 5
Elaine Chiquette and L. Michael Posey
4. Documentation of Pharmacy Services . . . . . . . . 7
George E. MacKinnon, III and Neil J. MacKinnon
5. Clinical Pharmacokinetics
and Pharmacodynamics . . . . . . . . . . . . . . . . . . . . . . . 9
Larry A. Bauer
6. Pharmacogenetics . . . . . . . . . . . . . . . . . . . . . . . . . . . 31
Larisa H. Cavallari and Y. W. Francis Lam
7. Pediatrics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 47
Milap C. Nahata and Carol Taketomo
8. Geriatrics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 57
Catherine I. Starner, Shelly L. Gray, David R. P. Guay,
Emily R. Hajjar, Steven M. Handler,
and Joseph T. Hanlon
9. Pharmacoepidemiology . . . . . . . . . . . . . . . . . . . 67
Andy Stergachis, Thomas K. Hazlet,
and Denise Boudreau
10. Clinical Toxicology . . . . . . . . . . . . . . . . . . . . . . . . . . 69
Peter A. Chyka

11. Emergency Preparedness: Identification and
Management of Biological Exposures . . . . . . . . 91
Colleen M. Terriff, Jason E. Brouillard,
Lisa T. Costanigro, and Jessica S. Gruber
12. Emergency Preparedness: Identification
and Management of Chemical and
Radiological Exposures . . . . . . . . . . . . . . . . . . . . 93
Greene Shepherd and Richard B. Schwartz
SECTION 2
Cardiovascular Disorders
Section Editor: Robert L. Talbert
13. Cardiovascular Testing . . . . . . . . . . . . . . . . . . . . . . . 95
Robert Chilton and Robert L. Talbert
14. Cardiopulmonary Arrest . . . . . . . . . . . . . . . . . . . . . 123
Jeffrey F. Barletta and Jeffrey L. Wilt
15. Hypertension . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 139
Joseph J. Saseen and Eric J. MacLaughlin
16. Heart Failure. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 173
Robert B. Parker, Jo E. Rodgers, and Larisa H. Cavallari
17. Ischemic Heart Disease . . . . . . . . . . . . . . . . . . . . . . 217
Robert L. Talbert
18. Acute Coronary Syndromes . . . . . . . . . . . . . . . . . . 249
Sarah A. Spinler and Simon de Denus
19. The Arrhythmias . . . . . . . . . . . . . . . . . . . . . . . . . . . 279
Cynthia A. Sanoski, Marieke Dekker Schoen,
and Jerry L. Bauman
20. Diastolic Heart Failure
and the Cardiomyopathies . . . . . . . . . . . . . . . . . . . 315
Jean M. Nappi and Robert L. Page, II
21. Venous Thromboembolism . . . . . . . . . . . . . . . . . . 331
Stuart T. Haines, Daniel M. Witt, and Edith A. Nutescu
22. Stroke. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 373
Susan C. Fagan and David C. Hess

CONTENTS

The complete chapter, learning objectives, and other resources can be found at www.pharmacotherapyonline.com.

For more information about this title, click here

CONTENTS
viii
23. Hyperlipidemia. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 385
Robert L. Talbert
24. Peripheral Arterial Disease . . . . . . . . . . . . . . . . . . . 409
Barbara J. Hoeben and Robert L. Talbert
25. Use of Vasopressors and Inotropes
in the Pharmacotherapy of Shock . . . . . . . . . . . . . 417
Robert MacLaren, Maria I. Rudis, and Joseph F. Dasta
26. Hypovolemic Shock . . . . . . . . . . . . . . . . . . . . . . . . . 441
Brian L. Erstad
SECTION 3
Respiratory Disorders
Section Editor: Robert L. Talbert
27. Introduction to Pulmonary Function Testing. . . . 455
Jay I. Peters and Stephanie M. Levine
28. Asthma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 463
H. William Kelly and Christine A. Sorkness
29. Chronic Obstructive Pulmonary Disease. . . . . . . . 495
Dennis M. Williams and Sharya V. Bourdet
30. Pulmonary Hypertension . . . . . . . . . . . . . . . . . 519
Robert L. Talbert, Rebecca Boudreaux, and Rebecca L. Owens
31. Drug-Induced Pulmonary Diseases . . . . . . . . . . . . 521
Hengameh H. Raissy, Michelle Harkins,
and Patricia L. Marshik
32. Cystic Fibrosis. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 535
Gary Milavetz
SECTION 4
Gastrointestinal Disorders
Section Editor: Joseph T. DiPiro
33. Evaluation of the Gastrointestinal Tract . . . . . . . . 547
Keith M. Olsen, Marie A. Chisholm, and Mark W. Jackson
34. Gastroesophageal Reflux Disease . . . . . . . . . . . . . . 555
Dianne B. Williams and Robert R. Schade
35. Peptic Ulcer Disease. . . . . . . . . . . . . . . . . . . . . . . . . 569
Rosemary R. Berardi and Lynda S. Welage
36. Inflammatory Bowel Disease. . . . . . . . . . . . . . . . . . 589
Brian A. Hemstreet and Joseph T. DiPiro
37. Nausea and Vomiting . . . . . . . . . . . . . . . . . . . . . . . 607
Cecily V. DiPiro

38. Diarrhea, Constipation, and Irritable
Bowel Syndrome . . . . . . . . . . . . . . . . . . . . . . . . . . . 617
William J. Spruill and William E. Wade
39. Portal Hypertension and Cirrhosis . . . . . . . . . . . . 633
Julie M. Sease, Edward G. Timm,
and James J. Stragand
40. Drug-Induced Liver Disease. . . . . . . . . . . . . . . . . . 651
William R. Kirchain and Rondall E. Allen
41. Pancreatitis. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 659
Rosemary R. Berardi and Patricia A. Montgomery
42. Viral Hepatitis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 675
Paulina Deming, Renee-Claude Mercier,
and Manjunath P. Pai
43. Drug Therapy Individualization in Patients
with Hepatic Disease or Genetic Alterations
in Drug Metabolizing Activity . . . . . . . . . . . . . . . . 693
Y. W. Francis Lam

SECTION 5
Renal Disorders
Section Editor: Gary R. Matzke
44. Quantification of Renal Function . . . . . . . . . . . . . 705
Thomas C. Dowling
45. Acute Renal Failure. . . . . . . . . . . . . . . . . . . . . . . . . 723
William Dager and Anne P. Spencer
46. Chronic Kidney Disease:
Progression-Modifying Therapies . . . . . . . . . . . . . 745
Melanie S. Joy, Abhijit Kshirsagar, and Nora Franceschini
47. Chronic Kidney Disease:
Management of Complications . . . . . . . . . . . . . . . 765
Joanna Q. Hudson
48. Hemodialysis and Peritoneal Dialysis . . . . . . . 793
Edward F. Foote and Harold J. Manley
49. Drug-Induced Kidney Disease . . . . . . . . . . . . . . . . 795
Thomas D. Nolin and Jonathan Himmelfarb
50. Glomerulonephritis. . . . . . . . . . . . . . . . . . . . . . . . . 811
Alan H. Lau
51. Drug Therapy Individualization for
Patients with Renal Insufficiency. . . . . . . . . . . . . . 833
Gary R. Matzke and Reginald F. Frye
52. Disorders of Sodium and Water Homeostasis . . . 845
James D. Coyle and Melanie S. Joy

The complete chapter, learning objectives, and other resources can be found at www.pharmacotherapyonline.com.

ix
CONTENTS

53. Disorders of Calcium and
Phosphorus Homeostasis . . . . . . . . . . . . . . . . . . . . 861
Amy Barton Pai, Mark Rohrscheib,
and Melanie S. Joy
54. Disorders of Potassium and
Magnesium Homeostasis . . . . . . . . . . . . . . . . . . . . 877
Donald F. Brophy and Todd W. B. Gehr
55. Acid–Base Disorders . . . . . . . . . . . . . . . . . . . . . . . . 889
John W. Devlin, Gary R. Matzke, and Paul M. Palevsky

SECTION 6
Neurologic Disorders
Section Editor: Barbara G. Wells
56. Evaluation of Neurologic Illness . . . . . . . . . . . . . . 909
Susan C. Fagan and Fenwick T. Nichols
57. Multiple Sclerosis . . . . . . . . . . . . . . . . . . . . . . . . . . 913
Jacquelyn L. Bainbridge and John R. Corboy
58. Epilepsy. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 927
Susan J. Rogers and Jose E. Cavazos
59. Status Epilepticus. . . . . . . . . . . . . . . . . . . . . . . . . . . 953
Stephanie J. Phelps, Collin A. Hovinga,
and James W. Wheless
60. Acute Management of the Brain Injury Patient . . .965
Bradley A. Boucher and Shelly D. Timmons
61. Parkinson’s Disease . . . . . . . . . . . . . . . . . . . . . . . . . 977
Jack J. Chen, Merlin V. Nelson, and David M. Swope
62. Pain Management . . . . . . . . . . . . . . . . . . . . . . . . . . 989
Terry J. Baumann and Jennifer Strickland
63. Headache Disorders . . . . . . . . . . . . . . . . . . . . . . . 1005
Deborah S. Minor and Marion R. Wofford

SECTION 7
Psychiatric Disorders
Section Editor: Barbara G. Wells
64. Evaluation of Psychiatric Illness . . . . . . . . . . . . . 1021
Patricia A. Marken, Mark E. Schneiderhan,
and Stuart Munro
65. Childhood Disorders. . . . . . . . . . . . . . . . . . . . . . . 1029
Julie Ann Dopheide, Jane Tran Tesoro, and Michael Malkin

66. Eating Disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . 1041
Steven C. Stoner
67. Alzheimer’s Disease . . . . . . . . . . . . . . . . . . . . . . . . 1051
Patricia W. Slattum, Russell H. Swerdlow,
and Angela Massey Hill
68. Substance-Related Disorders: Overview and
Depressants, Stimulants, and Hallucinogens. . . . 1067
Paul L. Doering and Lisa A. Boothby
69. Substance-Related Disorders: Alcohol,
Nicotine, and Caffeine . . . . . . . . . . . . . . . . . . . . . . 1083
Paul L. Doering, W. Klugh Kennedy, and Lisa A. Boothby
70. Schizophrenia . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1099
M. Lynn Crismon, Tami R. Argo, and Peter F. Buckley
71. Depressive Disorders . . . . . . . . . . . . . . . . . . . . . . . 1123
Christian J. Teter, Judith C. Kando, Barbara G. Wells,
and Peggy E. Hayes
72. Bipolar Disorder . . . . . . . . . . . . . . . . . . . . . . . . . . . 1141
Shannon J. Drayton and Benjamin L. Weinstein
73. Anxiety Disorders I: Generalized Anxiety,
Panic, and Social Anxiety Disorders. . . . . . . . . . . 1161
Cynthia K. Kirkwood and Sarah T. Melton
74. Anxiety Disorders II: Posttraumatic Stress Disorder
and Obsessive-Compulsive Disorder . . . . . . . . . . 1179
Cynthia K. Kirkwood, Eugene H. Makela,
and Barbara G. Wells
75. Sleep Disorders . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1191
John M. Dopp and Bradley G. Phillips
76. Developmental Disabilities . . . . . . . . . . . . . . . 1203
Nancy Brahm, Jerry McKee, and Robert C. Brown
SECTION 8
Endocrinologic Disorders
Section Editor: Robert L. Talbert
77. Diabetes Mellitus . . . . . . . . . . . . . . . . . . . . . . . . . . 1205
Curtis L. Triplitt, Charles A. Reasner, II, and William L. Isley
78. Thyroid Disorders . . . . . . . . . . . . . . . . . . . . . . . . . 1243
Steven I. Sherman and Robert L. Talbert
79. Adrenal Gland Disorders. . . . . . . . . . . . . . . . . . . . 1265
John G. Gums and Shawn Anderson
80. Pituitary Gland Disorders . . . . . . . . . . . . . . . . . . . 1281
Amy Heck Sheehan, Jack A. Yanovski, and Karim Anton Calis

The complete chapter, learning objectives, and other resources can be found at www.pharmacotherapyonline.com.

CONTENTS
x
SECTION 9
Gynecologic Disorders
Section Editor: Barbara G. Wells
81. Pregnancy and Lactation:
Therapeutic Considerations . . . . . . . . . . . . . . . . . 1297
Denise L. Walbrandt Pigarelli, Connie K. Kraus,
and Beth E. Potter
82. Contraception. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1313
Lori M. Dickerson, Sarah P. Shrader, and Vanessa A. Diaz
83. Menstruation-Related Disorders . . . . . . . . . . . . . 1329
Elena M. Umland, Lara C. Weinstein, and Edward Buchanan
84. Endometriosis. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1345
Deborah A. Sturpe
85. Hormone Therapy in Women . . . . . . . . . . . . . . . 1351
Sophia N. Kalantaridou, Susan R. Davis, and
Karim Anton Calis

SECTION 10
Urologic Disorders
Section Editor: L. Michael Posey
86. Erectile Dysfunction. . . . . . . . . . . . . . . . . . . . . . . . 1369
Mary Lee
87. Management of Benign
Prostatic Hyperplasia . . . . . . . . . . . . . . . . . . . . . . . 1387
Mary Lee
88. Urinary Incontinence. . . . . . . . . . . . . . . . . . . . . . . 1399
Eric S. Rovner, Jean Wyman, Thomas Lackner,
and David Guay

SECTION 11
Immunologic Disorders
Section Editor: Gary C. Yee
89. Function and Evaluation of the
Immune System . . . . . . . . . . . . . . . . . . . . . . . . . . . 1417
Philip D. Hall and Nicole A. Weimert
90. Systemic Lupus Erythematosus and Other
Collagen-Vascular Diseases . . . . . . . . . . . . . . . . . . 1431
Jeffrey C. Delafuente and Kimberly A. Cappuzzo
91. Allergic and Pseudoallergic Drug Reactions . . . . 1447
Joseph T. DiPiro
92. Solid-Organ Transplantation . . . . . . . . . . . . . . . . 1459
Kristine S. Schonder and Heather J. Johnson

SECTION 12
Rheumatologic Disorders
Section Editor: L. Michael Posey
93. Osteoporosis and Other Metabolic
Bone Diseases. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1483
Mary Beth O’Connell and Sheryl F. Vondracek
94. Rheumatoid Arthritis . . . . . . . . . . . . . . . . . . . . . . 1505
Arthur A. Schuna
95. Osteoarthritis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1519
Lucinda M. Buys and Mary Elizabeth Elliott
96. Gout and Hyperuricemia . . . . . . . . . . . . . . . . . . . 1539
Michael E. Ernst, Elizabeth C. Clark, and David W. Hawkins

SECTION 13
Ophthalmic and Otolaryngologic Disorders
Section Editor: L. Michael Posey
97. Glaucoma . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1551
Richard G. Fiscella, Timothy S. Lesar, and Deepak P. Edward
98. Allergic Rhinitis . . . . . . . . . . . . . . . . . . . . . . . . . . . 1565
J. Russell May and Philip H. Smith
SECTION 14
Dermatologic Disorders
Section Editor: L. Michael Posey
99. Dermatologic Drug Reactions and
Self-Treatable Skin Disorders. . . . . . . . . . . . . . . . 1577
Nina H. Cheigh
100. Acne Vulgaris. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1591
Dennis P. West, Amy Loyd, Kimberly A. Bauer, Lee E. West,
Laura Scuderi, and Giuseppe Micali
101. Psoriasis . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1603
Dennis P. West, Amy Loyd, Lee E. West, Kimberly A. Bauer,
Maria Letizia Musumeci, and Giuseppe Micali
102. Atopic Dermatitis . . . . . . . . . . . . . . . . . . . . . . . . . 1619
Nina H. Cheigh
SECTION 15
Hematologic Disorders
Section Editor: Gary C. Yee
103. Hematopoiesis . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1627
William P. Petros and Michael Craig

xi
CONTENTS

104. Anemias . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1639
Beata A. Ineck, Barbara J. Mason, and William L. Lyons
105. Coagulation Disorders . . . . . . . . . . . . . . . . . . . . . 1665
Betsy Bickert Poon and Char Witmer
106. Sickle Cell Disease . . . . . . . . . . . . . . . . . . . . . . . . . 1685
C. Y. Jennifer Chan and Reginald H. Moore
107. Drug-Induced Hematologic Disorders . . . . . . . . 1701
Dale H. Whitby and Thomas E. Johns
SECTION 16
Infectious Diseases
Section Editor: Joseph T. DiPiro
108. Laboratory Tests to Direct
Antimicrobial Pharmacotherapy . . . . . . . . . . . . . 1715
Michael J. Rybak and Jeffrey R. Aeschlimann
109. Antimicrobial Regimen Selection . . . . . . . . . . . . 1731
David S. Burgess
110. Central Nervous System Infections . . . . . . . . . . . 1743
Isaac F. Mitropoulos, Elizabeth D. Hermsen,
Jeremy A. Schafer, and John C. Rotschafer
111. Lower Respiratory Tract Infections . . . . . . . . . . . 1761
Mark L. Glover and Michael D. Reed
112. Upper Respiratory Tract Infections. . . . . . . . . . . 1779
Yasmin Khaliq, Sarah Forgie, and George Zhanel
113. Influenza. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1791
Elizabeth D. Hermsen and Mark E. Rupp
114. Skin and Soft-Tissue Infections . . . . . . . . . . . . . . 1801
Douglas N. Fish, Susan L. Pendland, and Larry H. Danziger
115. Infective Endocarditis . . . . . . . . . . . . . . . . . . . . . . 1821
Michael A. Crouch and Angie Veverka
116. Tuberculosis. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1839
Charles A. Peloquin
117. Gastrointestinal Infections and . . . . . . . . . . . . . . 1857
Enterotoxigenic Poisonings
Steven Martin and Rose Jung
118. Intraabdominal Infections . . . . . . . . . . . . . . . . . . 1875
Joseph T. DiPiro and Thomas R. Howdieshell
119. Parasitic Diseases . . . . . . . . . . . . . . . . . . . . . . . . . . 1887
J. V. Anandan
120. Urinary Tract Infections and Prostatitis . . . . . . . 1899
Elizabeth A. Coyle and Randall A. Prince
121. Sexually Transmitted Diseases . . . . . . . . . . . . . . . 1915
Leroy C. Knodel

122. Bone and Joint Infections . . . . . . . . . . . . . . . . . . . 1933
Edward P. Armstrong and Allan D. Friedman
123. Sepsis and Septic Shock . . . . . . . . . . . . . . . . . . . . . 1943
S. Lena Kang-Birken and Joseph T. DiPiro
124. Superficial Fungal Infections. . . . . . . . . . . . . . . . . 1957
Thomas E. R. Brown and Thomas W. F. Chin
125. Invasive Fungal Infections. . . . . . . . . . . . . . . . . . . 1973
Peggy L. Carver
126. Infections in Immunocompromised Patients . . . 2003
Douglas N. Fish
127. Antimicrobial Prophylaxis in Surgery . . . . . . . . . 2027
Salmaan Kanji and John W. Devlin
128. Vaccines, Toxoids, and
Other Immunobiologics . . . . . . . . . . . . . . . . . . . . 2041
Mary S. Hayney
129. Human Immunodeficiency Virus Infection . . . . 2065
Peter L. Anderson, Thomas N. Kakuda,
and Courtney V. Fletcher

SECTION 17
Oncologic Disorders
Section Editor: Gary C. Yee
130. Cancer Treatment and Chemotherapy . . . . . . . . 2085
Patrick J. Medina and Chris Fausel
131. Breast Cancer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2121
Laura Boehnke Michaud, Janet L. Espirito,
and Francisco J. Esteva
132. Lung Cancer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2157
Jeannine S. McCune and Deborah A. Frieze
133. Colorectal Cancer. . . . . . . . . . . . . . . . . . . . . . . . . . 2175
Patrick J. Medina, Weijing Sun, and Lisa E. Davis
134. Prostate Cancer. . . . . . . . . . . . . . . . . . . . . . . . . . . . 2207
Jill M. Kolesar
135. Lymphomas . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2219
Val R. Adams and Gary C. Yee
136. Ovarian Cancer. . . . . . . . . . . . . . . . . . . . . . . . . . . . 2245
Judith A. Smith and Judith K. Wolf
137. Acute Leukemias. . . . . . . . . . . . . . . . . . . . . . . . . . . 2259
Helen L. Leather and Betsy Bickert Poon
138. Chronic Leukemias . . . . . . . . . . . . . . . . . . . . . . . . 2281
Amy M. Pick, Marcel Devetten, and Timothy R. McGuire
139. Multiple Myeloma . . . . . . . . . . . . . . . . . . . . . . . . . 2295
Timothy R. McGuire

CONTENTS
xii
140. Myelodysplastic Syndromes . . . . . . . . . . . . . . 2309
Julianna A. Burzynski and Trevor McKibbin
141. Skin Cancer. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2311
Rowena N. Schwartz and Lindsay J. Corporon
142. Hematopoietic Stem Cell Transplantation . . . . . 2331
Janelle B. Perkins and Gary C. Yee
SECTION 18
Nutrition Disorders
Section Editor: Gary R. Matzke
143. Assessment of Nutrition Status and
Nutrition Requirements . . . . . . . . . . . . . . . . . . . . 2349
Katherine Hammond Chessman and Vanessa J. Kumpf

144. Prevalence and Significance of Malnutrition . . . 2367
Gordon Sacks and Catherine M. Crill
145. Parenteral Nutrition . . . . . . . . . . . . . . . . . . . . . . . 2379
Todd W. Mattox and Pamela D. Reiter
146. Enteral Nutrition. . . . . . . . . . . . . . . . . . . . . . . . . . 2399
Vanessa J. Kumpf and Katherine Hammond Chessman
147. Nutritional Considerations in Major
Organ Failure. . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2417
Brian M. Hodges and Mark DeLegge
148. Obesity . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2437
John V. St. Peter and Charles J. Billington
Glossary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2455
Index . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2581

 

DOWNLOAD